MicroRNA‐326 suppresses iNOS expression and promotes autophagy of dopaminergic neurons through the JNK signaling by targeting XBP1 in a mouse model of Parkinson's disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA‐326 suppresses iNOS expression and promotes autophagy of dopaminergic neurons through the JNK signaling by targeting XBP1 in a mouse model of Parkinson's disease
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-05-28
DOI
10.1002/jcb.28761
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNAs underlying memory deficits in neurodegenerative disorders
- (2017) Julia Hernandez-Rapp et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease
- (2017) Mohamed Salama et al. Experimental and Therapeutic Medicine
- The molecular mechanisms of XBP-1 gene silencing on IRE1α-TRAF2-ASK1-JNK pathways in oral squamous cell carcinoma under endoplasmic reticulum stress
- (2016) Haiying Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Exosome-shuttling microRNA-21 promotes cell migration and invasion-targeting PDCD4 in esophageal cancer
- (2016) JUAN LIAO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The role of photobiomodulation on gene expression of cell adhesion molecules in diabetic wounded fibroblasts in vitro
- (2016) Sandra M. Ayuk et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- MicroRNA-326 acts as a molecular switch in the regulation of midbrain urocortin 1 expression
- (2016) Armaz Aschrafi et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- miR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2
- (2016) XIAOJUAN ZHAO et al. Oncology Letters
- Effects of Propofol on the Liver Oxidative-Antioxidant Balance in a Rat Model of Parkinson’s Disease
- (2016) Ewa Romuk et al. Advances in Clinical and Experimental Medicine
- What Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum?
- (2016) Haruo Nishijima et al. Frontiers in Neuroscience
- PINK1 Deficiency Decreases Expression Levels of mir-326, mir-330, and mir-3099 during Brain Development and Neural Stem Cell Differentiation
- (2016) Insup Choi et al. Experimental Neurobiology
- Midbrain dopamine neurons in Parkinson׳s disease exhibit a dysregulated miRNA and target-gene network
- (2015) Christine E. Briggs et al. BRAIN RESEARCH
- Downregulated microRNA-222 is correlated with increased p27Kip1 expression in a double transgenic mouse model of Alzheimer's disease
- (2015) XIAOYING WANG et al. Molecular Medicine Reports
- To Be or Not to Be? How Selective Autophagy and Cell Death Govern Cell Fate
- (2014) Douglas R. Green et al. CELL
- Tetranectin Knockout Mice Develop Features of Parkinson Disease
- (2014) Er-song Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing–remitting multiple sclerosis
- (2014) Mohammad Amin Honardoost et al. GENE
- MicroRNA-9 and MicroRNA-326 Regulate Human Dopamine D2 Receptor Expression, and the MicroRNA-mediated Expression Regulation Is Altered by a Genetic Variant
- (2014) Sandra Shi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Longitudinal follow-up of autophagy and inflammation in brain of APPswePS1dE9 transgenic mice
- (2014) Arnaud François et al. Journal of Neuroinflammation
- Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1
- (2014) P. Valdes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
- (2013) Shuwei Qiu et al. Journal of Translational Medicine
- Differential Expression of MicroRNAs in Patients with Glioblastoma after Concomitant Chemoradiotherapy
- (2013) Edmond Changkyun Park et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- MicroRNA-326 Functions as a Tumor Suppressor in Glioma by Targeting the Nin One Binding Protein (NOB1)
- (2013) Jingxu Zhou et al. PLoS One
- Neuroprotection by Silencing iNOS Expression in a 6-OHDA Model of Parkinson’s Disease
- (2012) Min Li et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- A model of nitric oxide induced α-synuclein misfolding in Parkinson's disease
- (2012) David K. Stone et al. NEUROSCIENCE LETTERS
- Oxidative Stress in Genetic Mouse Models of Parkinson’s Disease
- (2012) Mustafa Varçin et al. Oxidative Medicine and Cellular Longevity
- MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function
- (2011) Elena Miñones-Moyano et al. HUMAN MOLECULAR GENETICS
- p38 MAPK–mediated regulation of Xbp1s is crucial for glucose homeostasis
- (2011) Jaemin Lee et al. NATURE MEDICINE
- Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K
- (2011) Chi-Jing Choong et al. NEUROTOXICOLOGY
- XBP1U inhibits the XBP1S-mediated upregulation of the iNOS gene expression in mammalian ER stress response
- (2010) FengJin Guo et al. CELLULAR SIGNALLING
- The Neuronal MicroRNA miR-326 Acts in a Feedback Loop with Notch and Has Therapeutic Potential against Brain Tumors
- (2009) B. Kefas et al. JOURNAL OF NEUROSCIENCE
- Homocysteine induces X-box-binding protein 1 splicing in the mice brain
- (2009) Toru Hosoi et al. NEUROCHEMISTRY INTERNATIONAL
- Protective effect against Parkinson's disease-related insults through the activation of XBP1
- (2008) Megumi Sado et al. BRAIN RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started